Resources
In a clinical physiology laboratory experiment, an undergraduate student performs an oral glucose tolerance test (OGTT). Venous blood samples are drawn via an indwelling catheter at (baseline after an overnight fast), followed immediately by ingestion of a standardized anhydrous glucose solution, with subsequent blood samples assayed spectrophotometrically at , , , and . The measured serum glucose concentrations are: , , , , and . (a) Calculate the average rate of glucose clearance from circulation during the recovery interval between and in . (b) Identify the endocrine cells, the specific peptide hormone secreted in response to hyperglycemia, and the intracellular glucose-sensing transporter and kinase in pancreatic beta cells responsible for triggering this negative feedback loop. (c) On the basis of the standard American Diabetes Association (ADA) diagnostic threshold ( for normal glucose tolerance), evaluate whether the student's glucose negative feedback regulatory circuit is functioning normally.
Answer and steps
Final answer
(a) ; (b) Pancreatic islet beta cells (-cells) secrete insulin; initial intracellular glucose sensing occurs via GLUT2 (or GLUT1 in humans) facilitated diffusion and phosphorylation by glucokinase (hexokinase IV); (c) The student's blood glucose is , confirming completely normal glucose tolerance and intact, robust homeostatic negative feedback.
Steps
Part (a): Calculating the Average Rate of Glucose Clearance
The recovery phase begins after the peak concentration at and continues until the end of the test at .
-
Identify the initial and final values for the interval:
- At ,
- At ,
- Compute the change in concentration () and elapsed time ():
- Calculate the average rate of clearance:
(Pitfall: Ensure the rate reflects clearance or removal as a positive rate of decrease, rather than confusing the sign of the overall derivative.)
Part (b): Molecular and Endocrine Components of the Feedback Loop
- Endocrine Cells: Pancreatic beta cells (-cells), located within the islets of Langerhans of the pancreas.
- Peptide Hormone: Insulin, which stimulates glucose uptake in peripheral target tissues (skeletal muscle and adipose tissue via GLUT4 translocation) and inhibits hepatic gluconeogenesis and glycogenolysis.
- Glucose Transporter: GLUT2 (or GLUT1 in human -cells), which facilitates non-rate-limiting glucose diffusion into the cell in direct proportion to extracellular levels.
- Intracellular Kinase (Sensor): Glucokinase (hexokinase IV). Because glucokinase has a lower affinity (higher ) for glucose and is not inhibited by its product (glucose-6-phosphate), it acts as the primary molecular "glucose sensor," determining the rate of glycolytic flux, ATP production, ATP-sensitive channel closure, depolarization, influx, and exocytosis of insulin.
Part (c): Evaluation Against Diagnostic Standards
- According to clinical guidelines from the American Diabetes Association (ADA):
- Normal Glucose Tolerance (NGT):
- Impaired Glucose Tolerance (Prediabetes):
- Diabetes Mellitus:
The student's () serum glucose concentration is:
Because the level has completely returned to near-fasting baseline, the student's glucose negative feedback regulatory circuit is functioning normally, demonstrating robust and intact homeostatic control.
Typical errors
01 The student calculates the rate of change over the entire test duration from t = 0 to t = 120 min rather than the specified recovery interval from t = 30 to t = 120 min.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
You evaluated the change over the entire duration from to . The prompt asked for the clearance during the recovery interval starting after the peak concentration at () through (), spanning an elapsed time of .
- Step 2
- Step 3
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly recalled the cell type, peptide hormone, transporter, and metabolic sensor responsible for glucose homeostasis.
You accurately applied the American Diabetes Association threshold to evaluate glucose tolerance.
You set up the rate calculation formula correctly as change in concentration divided by change in time.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou used the baseline fasting time () as the initial point rather than the specified start of the recovery interval at peak glucose concentration (). In dynamic physiological tests, clearance specifically refers to the elimination phase after peak absorption.
REASONING PATH
Your ACEpath teacher’s suggested approach- Identify Physiological Test Phases
An oral tolerance curve consists of an absorption/appearance phase (rising to peak) and a clearance/recovery phase (falling from peak to baseline).
Always verify the interval boundaries specified in the problem statement before calculating rates of change.
CORRECTED PATH
ACEpath Teacher's Demonstration02 The student confuses the counter-regulatory hormone glucagon and alpha cells with insulin and beta cells responding to hyperglycemia.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
- Step 2
Endocrine cells: pancreatic alpha cells ⟹ Hormone: glucagon ⟹ Transporter: GLUT2 ⟹ Kinase: glucokinase
CorrectEndocrine cells: Pancreatic beta cells (-cells) ⟹ Hormone: Insulin ⟹ Transporter: GLUT2 (or GLUT1) ⟹ Kinase: Glucokinase (hexokinase IV)
You correctly identified the glucose-sensing elements GLUT2 and glucokinase, but an elevated blood glucose level (hyperglycemia) stimulates pancreatic beta cells to secrete insulin, not alpha cells secreting glucagon.
- Step 3
⟹ The glucose negative feedback circuit is functioning normally.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly computed the rate of glucose clearance across the recovery interval with proper units.
You accurately identified GLUT2 and glucokinase as the key molecular glucose-sensing machinery.
You correctly applied the ADA diagnostic criteria to assess normal glucose tolerance.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou swapped the endocrine cell type and hormone involved in blood sugar lowering with those involved in blood sugar raising. High blood glucose (hyperglycemia) triggers beta cells to secrete insulin to promote glucose storage and clearance, whereas low blood glucose (hypoglycemia) triggers alpha cells to secrete glucagon to elevate blood sugar.
REASONING PATH
Your ACEpath teacher’s suggested approach- Identify Stimulus Direction
Hyperglycemia (blood sugar ) stimulates insulin release; hypoglycemia () stimulates glucagon release.
Check whether circulating glucose is rising above or falling below baseline before selecting the hormone.
- Match Cell Type to Hormone
Pancreatic -cells secrete insulin; pancreatic -cells secrete glucagon.
Pair beta cells with insulin for glucose uptake, and alpha cells with glucagon for hepatic glucose release.
CORRECTED PATH
ACEpath Teacher's DemonstrationState the stimulus: Ingestion of glucose causes blood glucose to rise from to (hyperglycemia).
Identify the effector cells: High blood glucose stimulates pancreatic islet -cells (not -cells).
Identify the secreted hormone: -cells secrete insulin to lower blood glucose by promoting peripheral uptake and inhibiting hepatic output.
Retain the molecular sensors: Glucose enters -cells via GLUT2 and is phosphorylated by glucokinase to trigger insulin granule exocytosis.
(a) ; (b) Pancreatic beta cells, insulin, GLUT2, glucokinase; (c) , indicating normal glucose tolerance and functional homeostatic feedback.
03 The student identifies hexokinase instead of the specialized low-affinity glucose-sensing enzyme glucokinase in pancreatic beta cells.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
- Step 2
Endocrine cells : beta cells of pancreatic islets Hormone : insulin Transporter : GLUT2
- Step 3
Kinase : hexokinase
CorrectGlucokinase (hexokinase IV)
You wrote hexokinase without specifying glucokinase (hexokinase IV). While glucokinase belongs to the hexokinase family, common hexokinases (types I–III) have a very low and operate near even at fasting levels, whereas glucokinase has a high and lacks product inhibition, allowing it to act as the physiological glucose sensor.
- Step 4
, which is less than $140 $
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly computed the rate of glucose clearance across the recovery interval.
You correctly identified pancreatic beta cells and insulin as the endocrine mediators of glucose uptake.
You recognized the physiological relevance of GLUT2 in facilitating glucose transport into beta cells.
You accurately applied the ADA 2-hour diagnostic criteria to evaluate glucose tolerance.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou overlooked the unique kinetic properties that distinguish glucokinase (hexokinase IV) from standard hexokinases (I–III). Because glucokinase has a substantially higher (around ) and is not allosterically inhibited by glucose-6-phosphate, its phosphorylation rate varies linearly across physiological glucose concentrations, making it the indispensable molecular glucose sensor for insulin release.
REASONING PATH
Your ACEpath teacher’s suggested approach- Distinguishing Hexokinase Isozymes
Hexokinases I–III have low (high affinity) and are saturated at fasting glucose levels (), whereas glucokinase (hexokinase IV) has high (low affinity) and changes velocity dynamically across postprandial glucose fluctuations.
Always specify glucokinase (or hexokinase IV) when describing the glucose-sensing trigger of pancreatic beta cells.
CORRECTED PATH
ACEpath Teacher's DemonstrationRecognize that the metabolic sensor in pancreatic beta cells must alter glycolytic flux proportionally to rising blood glucose levels ().
Identify that hexokinases I–III are already saturated at fasting levels and subject to product inhibition by glucose-6-phosphate, preventing dynamic sensing.
Conclude that the specialized isozyme glucokinase (hexokinase IV) serves as the true molecular glucose sensor.
(a) ; (b) Pancreatic islet beta cells, insulin, GLUT2, and glucokinase (hexokinase IV); (c) The student's regulatory circuit is functioning normally ().
Lock it in
In an oral glucose tolerance test (OGTT) curve, what distinct physiological phases do the rising limb and falling limb represent?
The rising limb represents intestinal absorption and entry into circulation, while the falling limb represents insulin-mediated tissue uptake and glucose clearance.
Similar question
During an intravenous glucose tolerance test (IVGTT), a patient's plasma glucose concentration is at (immediately post-infusion) and declines to at . Calculate the average rate of glucose clearance over this recovery interval in .
Answer
. Steps: ; ; .
In a pharmacological clearance experiment, drug plasma concentration peaks at at and drops to at . Baseline at was . Determine the clearance rate over the elimination phase and explain why using would be incorrect.
Answer
. Steps: over ; . Using conflates drug administration/absorption with clearance.
An OGTT yields the following values: , , , and . (a) Calculate the average clearance rate between and . (b) Classify the patient's glucose tolerance status based on ADA criteria ( normal, prediabetes/impaired, diabetes).
Answer
(a) (computed as ). (b) Normal glucose tolerance, because .